首页>
外国专利>
PROTEASE BASED SWITCH CHIMERIC ANTIGEN RECEPTORS FOR SAFER CELL IMMUNOTHERAPY
PROTEASE BASED SWITCH CHIMERIC ANTIGEN RECEPTORS FOR SAFER CELL IMMUNOTHERAPY
展开▼
机译:基于蛋白质的开关嵌合抗原受体用于安全性细胞免疫治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the field of cell immunotherapy and more particularly to a new generation of chimeric antigen receptors (CAR). These new CARs are primarily expressed into cells under the form of chimeric polypeptide precursors that can be made active by a protease and switched-off upon addition of a protease inhibitor. Once activated by the protease, such CARs reach the surface of the immune cells and bind specific antigens. More specifically, the presentation of these CARs at the cells' surface is made controllable by inclusion in their polypeptide structure of a protease domain and/or a degradation domain (e.g. degron).
展开▼